Table 5

Univariate regression model

VariableOdds ratioLower CIUpper CIP value
1CHADSVASC1.7151.0832.7160.0214
2EF0.9020.8200.9920.0331
3Age1.1191.0011.2520.0473
4Female2.8850.74711.1380.1243
5HTN5.2500.63143.6460.1249
6ACTMAX1.0140.9961.0330.1296
7DAYPROCMR1.5590.8662.8040.1386
8CAD3.5510.59021.3810.1665
9CHADS1.5580.8252.9390.1714
10RF2.1480.5458.4640.2744
11FLUORO0.9630.8561.0840.5340
12ACT2500.6510.1682.5270.5350
13ACTLOW1.0040.9891.0190.5797
14PAF0.6720.1572.8840.5931
15PREPROCIN1.3300.4603.8430.5981
16AAD0.6770.1273.6180.6482
17ACT3000.8060.1574.1410.7958
18LA0.9830.8631.1210.8032
19Stroke1.2970.14012.0300.8193
20CV1.1220.2654.7510.8753
21PERSIST1.0830.2434.8270.9164
22DM1.0950.1209.9580.9356
23LASER0.9490.2543.5470.9376
24PROCTIME1.0000.9881.0130.9439
VariableOdds ratioLower CIUpper CIP value
1CHADSVASC1.7151.0832.7160.0214
2EF0.9020.8200.9920.0331
3Age1.1191.0011.2520.0473
4Female2.8850.74711.1380.1243
5HTN5.2500.63143.6460.1249
6ACTMAX1.0140.9961.0330.1296
7DAYPROCMR1.5590.8662.8040.1386
8CAD3.5510.59021.3810.1665
9CHADS1.5580.8252.9390.1714
10RF2.1480.5458.4640.2744
11FLUORO0.9630.8561.0840.5340
12ACT2500.6510.1682.5270.5350
13ACTLOW1.0040.9891.0190.5797
14PAF0.6720.1572.8840.5931
15PREPROCIN1.3300.4603.8430.5981
16AAD0.6770.1273.6180.6482
17ACT3000.8060.1574.1410.7958
18LA0.9830.8631.1210.8032
19Stroke1.2970.14012.0300.8193
20CV1.1220.2654.7510.8753
21PERSIST1.0830.2434.8270.9164
22DM1.0950.1209.9580.9356
23LASER0.9490.2543.5470.9376
24PROCTIME1.0000.9881.0130.9439

CI, confidence interval; CHADASVASC, CHA2DS2VASc score; EF, ejection fraction; HTN, hypertension; ACTMAX, maximum ACT; DAYPROCMRI, days between procedure and post-procedural MRI; CAD, coronary artery disease; CHADS, CHADS2 score; RF, radiofrequency; FLURO, fluoroscopy; ACT250, ACT value <250; ACTLOW, lowest ACT value; PAF, paroxysmal atrial fibrillation; PREPROCINR, pre-procedural INR; AAD, antiarrhythmic drug; ACT300, ACT value <300; LA, left atrium; CV, electrical cardioversion; PERSIST, persistent atrial fibrillation; DM, diabetes mellitus; LASER, laserballoon; PROCTIME, procedure time.

Table 5

Univariate regression model

VariableOdds ratioLower CIUpper CIP value
1CHADSVASC1.7151.0832.7160.0214
2EF0.9020.8200.9920.0331
3Age1.1191.0011.2520.0473
4Female2.8850.74711.1380.1243
5HTN5.2500.63143.6460.1249
6ACTMAX1.0140.9961.0330.1296
7DAYPROCMR1.5590.8662.8040.1386
8CAD3.5510.59021.3810.1665
9CHADS1.5580.8252.9390.1714
10RF2.1480.5458.4640.2744
11FLUORO0.9630.8561.0840.5340
12ACT2500.6510.1682.5270.5350
13ACTLOW1.0040.9891.0190.5797
14PAF0.6720.1572.8840.5931
15PREPROCIN1.3300.4603.8430.5981
16AAD0.6770.1273.6180.6482
17ACT3000.8060.1574.1410.7958
18LA0.9830.8631.1210.8032
19Stroke1.2970.14012.0300.8193
20CV1.1220.2654.7510.8753
21PERSIST1.0830.2434.8270.9164
22DM1.0950.1209.9580.9356
23LASER0.9490.2543.5470.9376
24PROCTIME1.0000.9881.0130.9439
VariableOdds ratioLower CIUpper CIP value
1CHADSVASC1.7151.0832.7160.0214
2EF0.9020.8200.9920.0331
3Age1.1191.0011.2520.0473
4Female2.8850.74711.1380.1243
5HTN5.2500.63143.6460.1249
6ACTMAX1.0140.9961.0330.1296
7DAYPROCMR1.5590.8662.8040.1386
8CAD3.5510.59021.3810.1665
9CHADS1.5580.8252.9390.1714
10RF2.1480.5458.4640.2744
11FLUORO0.9630.8561.0840.5340
12ACT2500.6510.1682.5270.5350
13ACTLOW1.0040.9891.0190.5797
14PAF0.6720.1572.8840.5931
15PREPROCIN1.3300.4603.8430.5981
16AAD0.6770.1273.6180.6482
17ACT3000.8060.1574.1410.7958
18LA0.9830.8631.1210.8032
19Stroke1.2970.14012.0300.8193
20CV1.1220.2654.7510.8753
21PERSIST1.0830.2434.8270.9164
22DM1.0950.1209.9580.9356
23LASER0.9490.2543.5470.9376
24PROCTIME1.0000.9881.0130.9439

CI, confidence interval; CHADASVASC, CHA2DS2VASc score; EF, ejection fraction; HTN, hypertension; ACTMAX, maximum ACT; DAYPROCMRI, days between procedure and post-procedural MRI; CAD, coronary artery disease; CHADS, CHADS2 score; RF, radiofrequency; FLURO, fluoroscopy; ACT250, ACT value <250; ACTLOW, lowest ACT value; PAF, paroxysmal atrial fibrillation; PREPROCINR, pre-procedural INR; AAD, antiarrhythmic drug; ACT300, ACT value <300; LA, left atrium; CV, electrical cardioversion; PERSIST, persistent atrial fibrillation; DM, diabetes mellitus; LASER, laserballoon; PROCTIME, procedure time.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close